Acquisition Of Prostiva Radio Frequency Therapy (Pro-Forma Financial Information) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended	6 Months Ended
	Dec. 31, 2011	Dec. 31, 2011
Acquisition Of Prostiva Radio Frequency Therapy [Abstract]
Pro forma net revenue	$ 4,653	$ 9,051
Pro forma net loss	$ (1,254)	$ (2,445)
Pro forma net loss per share (basic)	$ (0.09)	$ (0.17)
Pro forma net loss per share (diluted)	$ (0.09)	$ (0.17)